Sci—Fri PM: Dosimetry—06: Commissioning of a 3D patient specific QA system for hypofractionated prostate treatments
- CancerCare Manitoba (Canada)
The objective of this work is to commission the 6MV-SRS beam model in COMPASS (v2.1, IBA-Dosimetry) and validate its use for patient specific QA of hypofractionated prostate treatments. The COMPASS system consists of a 2D ion chamber array (MatriXX{sup Evolution}), an independent gantry angle sensor and associated software. The system can either directly calculate or reconstruct (using measured detector responses) a 3D dose distribution on the patient CT dataset for plan verification. Beam models are developed and commissioned in the same manner as a beam model is commissioned in a standard treatment planning system. Model validation was initially performed by comparing both COMPASS calculations and reconstructions to measured open field beam data. Next, 10 hypofractionated prostate RapidArc plans were delivered to both the COMPASS system and a phantom with ion chamber and film inserted. COMPASS dose distributions calculated and reconstructed on the phantom CT dataset were compared to the chamber and film measurements. The mean (± standard deviation) difference between COMPASS reconstructed dose and ion chamber measurement was 1.4 ± 1.0%. The maximum discrepancy was 2.6%. Corresponding values for COMPASS calculation were 0.9 ± 0.9% and 2.6%, respectively. The average gamma agreement index (3%/3mm) for COMPAS reconstruction and film was 96.7% and 95.3% when using 70% and 20% dose thresholds, respectively. The corresponding values for COMPASS calculation were 97.1% and 97.1%, respectively. Based on our results, COMPASS can be used for the patient specific QA of hypofractionated prostate treatments delivered with the 6MV-SRS beam.
- OSTI ID:
- 22409496
- Journal Information:
- Medical Physics, Journal Name: Medical Physics Journal Issue: 8 Vol. 41; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Patient-Specific 3D Pretreatment and Potential 3D Online Dose Verification of Monte Carlo-Calculated IMRT Prostate Treatment Plans
Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array
SU-E-T-77: Comparison of 2D and 3D Gamma Analysis in Patient-Specific QA for Prostate VMAT Plans
Journal Article
·
Mon Nov 14 23:00:00 EST 2011
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22054454
Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array
Journal Article
·
Sun Nov 14 23:00:00 EST 2010
· Medical Physics
·
OSTI ID:22096816
SU-E-T-77: Comparison of 2D and 3D Gamma Analysis in Patient-Specific QA for Prostate VMAT Plans
Journal Article
·
Sun Jun 01 00:00:00 EDT 2014
· Medical Physics
·
OSTI ID:22339844